|
Patient selection for neuroprotectants in clinical trials and for clinical use
Gregory Albers
|
|
From GABA to the CLASS trial of ZENDRA (clomethiazole) in stroke
Ashfaq Shuaib
|
|
CLASS-I, CLASS-H and CLASS-T - The Phase III programme for ZENDRA (clomethiazole) as a candidate neuroprotectant
Patrick D Lyden
|
|
New horizons for the management of acute stroke - NXY-059, a nitrone-based free radical trapping agent
Kennedy R Lees
|
|
Setting new management standards in acute stroke - Potential impact of neuroprotectants
Stephen M Davis
|
|
A reception will be held outside the John Batman Theatre from 4.45pm
|